O'Neil Global Advisors, Inc. Dexcom Inc Transaction History

O'Neil Global Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$112.47 - $130.98 $9.65 Million - $11.2 Million	-85,845 Closed	0 $0
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $9.38 Million - $10.9 Million	83,423 Added 3444.38%	85,845 $11 Million
Q1 2023 Apr 14, 2023	SELL	$104.0 - $122.92 $275,600 - $325,738	-2,650 Reduced 52.25%	2,422 $281,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $431,018 - $622,182	5,072 New	5,072 $574,000
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $1.4 Million - $1.75 Million	-10,743 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$106.71 - $143.18 $1.15 Million - $1.54 Million	10,743 New	10,743 $5.88 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of O'Neil Global Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on O'Neil Global Advisors, Inc. with notifications on news.